Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CUBICIN Cause Antimicrobial susceptibility test resistant? 14 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Antimicrobial susceptibility test resistant have been filed in association with CUBICIN. This represents 5.7% of all adverse event reports for CUBICIN.

14
Reports of Antimicrobial susceptibility test resistant with CUBICIN
5.7%
of all CUBICIN reports
3
Deaths
4
Hospitalizations

How Dangerous Is Antimicrobial susceptibility test resistant From CUBICIN?

Of the 14 reports, 3 (21.4%) resulted in death, 4 (28.6%) required hospitalization.

Is Antimicrobial susceptibility test resistant Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CUBICIN. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does CUBICIN Cause?

Death (30) Drug ineffective for unapproved indication (17) Staphylococcal bacteraemia (17) Drug ineffective (16) Blood creatine phosphokinase increased (13) Pyrexia (12) Eosinophilic pneumonia (11) Cardiac valve vegetation (9) Enterococcal bacteraemia (9) Overdose (9)

What Other Drugs Cause Antimicrobial susceptibility test resistant?

DAPTOMYCIN (97) VANCOMYCIN (44) DUTASTERIDE (30) ALFUZOSIN (29) LANSOPRAZOLE (29) TRAMADOL (27) BISOPROLOL (25) CILASTATIN\IMIPENEM (15) CIPROFLOXACIN (11) PIPERACILLIN\TAZOBACTAM (11)

Which CUBICIN Alternatives Have Lower Antimicrobial susceptibility test resistant Risk?

CUBICIN vs CUPRIC CUBICIN vs CUPRIC ANHYDROUS CUBICIN vs CUPRIC\FOLIC ACID\NIACIN\ZINC CUBICIN vs CX-024414 CUBICIN vs CYAMEMAZINE

Related Pages

CUBICIN Full Profile All Antimicrobial susceptibility test resistant Reports All Drugs Causing Antimicrobial susceptibility test resistant CUBICIN Demographics